Universität zu Köln

Pilotto, A., Sancarlo, D., Polidori, M. C., Cruz-Jentoft, A. J., Mattace-Raso, F., Paccalin, M., Topinkova, E., Welmer, A. -K. and Maggi, S. (2015). The MPI_AGE European Project: Using Multidimensional Prognostic Indices (MPI) to improve cost-effectiveness of interventions in multimorbid frail older persons. Background, aim and design. Eur. Geriatr. Med., 6 (2). S. 184 - 189. NEW YORK: SPRINGER. ISSN 1878-7657

Full text not available from this repository.

Abstract

Purpose: The MPI_AGE project is a multicenter project co-funded by the Executive Agency for Health and Consumers in the frame of Active and Healthy Ageing 2nd-Health Programme 2008-2013. Aim of the project is to implement Multidimensional Prognostic Indices (MPI) that predict survival, based on the Comprehensive Geriatric Assessment, in order to improve the cost-effectiveness of health interventions in frail older individuals with multimorbidity and polypharmacy. Materials and methods: The project is divided in seven Work Packages (WP). WP1, WP2 and WP3 include the activities of coordination, evaluation and dissemination, respectively. WP4 is a retrospective analysis of clinical, functional and administrative data carried out in order to develop and validate MPI in community-dwelling older subjects. In WP5, the best cost-effective profile of different therapeutic interventions in older individuals with different MPI-based mortality risk profile will be identified. WP6 is a multicenter prospective study with a follow-up of 12 months carried out in 11 geriatric clinical centres with the aim of evaluating the usefulness of the MPI in the clinical decision making in patients with different mortality risk. In WP7, a systematic process of recommendations will be carried out through the wide involvement of partners, external experts and stakeholders in meetings and web diffusion. Conclusions: Mortality risk may influence the effectiveness of specific treatments and interventions in frail older subjects with multimorbidity and polypharmacy. Clinicians and health policy makers need to consider the prognostic information obtained through the MPI to identify those setting-specific profiles of older subjects who may better benefit from interventions. (C) 2015 Elsevier Masson SAS and European Union Geriatric Medicine Society. All rights reserved.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Pilotto, A. UNSPECIFIED UNSPECIFIED UNSPECIFIED Sancarlo, D. UNSPECIFIED UNSPECIFIED UNSPECIFIED Polidori, M. C. UNSPECIFIED UNSPECIFIED UNSPECIFIED Cruz-Jentoft, A. J. UNSPECIFIED UNSPECIFIED UNSPECIFIED Mattace-Raso, F. UNSPECIFIED UNSPECIFIED UNSPECIFIED Paccalin, M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Topinkova, E. UNSPECIFIED UNSPECIFIED UNSPECIFIED Welmer, A. -K. UNSPECIFIED UNSPECIFIED UNSPECIFIED Maggi, S. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-408948
DOI:	10.1016/j.eurger.2015.01.012
Journal or Publication Title:	Eur. Geriatr. Med.
Volume:	6
Number:	2
Page Range:	S. 184 - 189
Date:	2015
Publisher:	SPRINGER
Place of Publication:	NEW YORK
ISSN:	1878-7657
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language COMPREHENSIVE GERIATRIC ASSESSMENT; LONG-TERM MORTALITY; VALIDATION; DEMENTIA; PREDICT; TRIALS; ADULTS; DEATH; LIFE Multiple languages Geriatrics & Gerontology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/40894